<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Vabgen Rx – Clinical Intelligence Platform</title>
<link href="https://fonts.googleapis.com/css2?family=Outfit:wght@300;400;500;600;700;800&family=JetBrains+Mono:wght@400;500&display=swap" rel="stylesheet">
<style>
*,*::before,*::after{box-sizing:border-box;margin:0;padding:0}
:root{
  --navy:#0a1628;
  --navy2:#112240;
  --blue:#1a6cf5;
  --blue2:#3d86ff;
  --blue-pale:#e8f1ff;
  --red:#c0392b;--red-lt:#fff0ef;--red-bd:#ffc9c5;
  --orange:#d97706;--orange-lt:#fff8ed;
  --green:#059669;--green-lt:#edfaf4;
  --gray-50:#f7f9fc;--gray-100:#eef2f8;--gray-200:#dde4f0;
  --gray-400:#8fa3bf;--gray-600:#4a5f7a;--gray-800:#1a2a3d;
  --white:#fff;
  --shadow:0 2px 12px rgba(10,22,40,.09);
  --shadow-lg:0 8px 32px rgba(10,22,40,.14);
  --r:10px;--r-sm:6px;
}
body{font-family:'Outfit',sans-serif;background:#e8edf6;color:var(--gray-800);font-size:13.5px;min-height:100vh}

/* ─── TOPNAV ─── */
.topnav{
  background:var(--navy);
  height:56px;display:flex;align-items:center;justify-content:space-between;
  padding:0 24px;position:sticky;top:0;z-index:200;
  box-shadow:0 2px 16px rgba(0,0,0,.25);
}
/* SVG LOGO in nav */
.brand{display:flex;align-items:center;gap:13px;text-decoration:none}
.brand-logo-wrap{
  position:relative;width:46px;height:46px;flex-shrink:0;
}
.brand-logo-img{
  width:46px;height:46px;border-radius:50%;
  object-fit:cover;object-position:center center;
  border:2px solid rgba(91,163,255,.5);
  box-shadow:0 0 0 0 rgba(91,163,255,.6),0 2px 10px rgba(10,22,40,.4);
  animation:logoBlink 3s ease-in-out infinite;
  background:#fff;
  display:block;
}
.brand-logo-dot{
  position:absolute;bottom:2px;right:2px;
  width:10px;height:10px;border-radius:50%;
  background:#22c55e;
  border:2px solid var(--navy);
  animation:dotPulse 2.5s ease-in-out infinite;
}
@keyframes logoBlink{
  0%,100%{box-shadow:0 0 0 0 rgba(91,163,255,.0),0 2px 10px rgba(10,22,40,.4);border-color:rgba(91,163,255,.3)}
  40%{box-shadow:0 0 0 5px rgba(91,163,255,.25),0 2px 14px rgba(26,108,245,.35);border-color:rgba(91,163,255,.8)}
  60%{box-shadow:0 0 0 8px rgba(91,163,255,.1),0 2px 14px rgba(26,108,245,.2);border-color:rgba(91,163,255,.6)}
}
@keyframes dotPulse{
  0%,100%{opacity:1;transform:scale(1)}
  50%{opacity:.5;transform:scale(.75)}
}
.brand-text{display:flex;align-items:baseline;gap:0}
.brand-text .vab{font-size:20px;font-weight:800;color:#fff;letter-spacing:-.5px}
.brand-text .gen{font-size:20px;font-weight:300;color:#a8c4ff;letter-spacing:-.5px}
.brand-text .rx{font-size:20px;font-weight:800;color:#5ba3ff;letter-spacing:-.5px;margin-left:4px}
.brand-tagline{font-size:9px;color:#6b8db8;letter-spacing:1.8px;text-transform:uppercase;margin-top:-2px}
.brand-wrap{display:flex;flex-direction:column}

.nav-right{display:flex;align-items:center;gap:18px}
.nav-pill{
  display:flex;align-items:center;gap:7px;
  color:#c8d8ef;font-size:12.5px;cursor:pointer;
  padding:5px 11px;border-radius:20px;
  transition:background .2s,color .2s;
}
.nav-pill:hover{background:rgba(255,255,255,.08);color:#fff}
.notif-dot{
  background:#ef4444;color:#fff;font-size:9.5px;font-weight:700;
  border-radius:10px;padding:1px 5px;margin-left:1px;
}

/* ─── MAIN ─── */
.main{padding:14px 18px;max-width:1140px;margin:0 auto}

/* ─── PATIENT HEADER ─── */
.patient-header{
  background:var(--white);border-radius:var(--r);
  padding:13px 18px;display:flex;align-items:center;gap:14px;
  margin-bottom:12px;box-shadow:var(--shadow);
  border-left:4px solid var(--blue);
}
.pat-avatar{
  width:44px;height:44px;border-radius:50%;
  background:linear-gradient(135deg,#dbeafe,#bfdbfe);
  display:flex;align-items:center;justify-content:center;font-size:20px;flex-shrink:0;
}
.pat-name{font-size:17px;font-weight:700;color:var(--navy)}
.pat-meta{display:flex;gap:14px;margin-top:3px;font-size:12px;color:var(--gray-600);flex-wrap:wrap}
.cond-tag{background:var(--blue-pale);color:var(--blue);padding:1px 8px;border-radius:20px;font-size:11px;font-weight:600}
.allergy-strip{
  background:#fff8ed;border:1px solid #fde68a;border-radius:var(--r-sm);
  padding:7px 13px;display:flex;align-items:center;gap:7px;margin-left:auto;
  font-size:12px;color:#92400e;max-width:460px;
}

/* ─── RISK BANNER ─── */
.risk-banner{
  background:linear-gradient(135deg,#7f1d1d 0%,#991b1b 60%,#b91c1c 100%);
  border-radius:var(--r);padding:12px 18px;
  display:flex;align-items:center;justify-content:space-between;
  margin-bottom:12px;box-shadow:0 4px 20px rgba(153,27,27,.35);
}
.risk-l{display:flex;align-items:center;gap:12px}
.risk-ring{
  width:46px;height:46px;border-radius:50%;
  border:2.5px solid rgba(255,255,255,.45);
  background:rgba(255,255,255,.12);
  display:flex;align-items:center;justify-content:center;
  font-size:22px;font-weight:900;color:#fff;
}
.risk-label-sm{font-size:11px;color:rgba(255,255,255,.7);text-transform:uppercase;letter-spacing:.8px}
.risk-title{font-size:15px;font-weight:700;color:#fff;margin-top:2px}
.btn-wh{
  border:1.5px solid rgba(255,255,255,.35);color:#fff;background:transparent;
  padding:6px 14px;border-radius:var(--r-sm);font-size:12px;font-weight:600;cursor:pointer;
  font-family:'Outfit',sans-serif;transition:background .2s;
}
.btn-wh:hover{background:rgba(255,255,255,.15)}

/* ─── STAT ROW ─── */
.stat-row{display:grid;grid-template-columns:repeat(3,1fr);gap:12px;margin-bottom:12px}
.stat-card{
  background:var(--white);border-radius:var(--r);
  padding:13px 15px;display:flex;align-items:center;gap:12px;
  box-shadow:var(--shadow);
}
.stat-ico{
  width:42px;height:42px;border-radius:10px;
  display:flex;align-items:center;justify-content:center;font-size:19px;flex-shrink:0;
}
.ico-blue{background:var(--blue-pale)}
.ico-red{background:var(--red-lt)}
.ico-orange{background:var(--orange-lt)}
.stat-num{font-size:24px;font-weight:800;line-height:1}
.stat-lbl{font-size:11.5px;color:var(--gray-600);margin-top:2px}
.trend-bar-row{display:flex;align-items:flex-end;gap:3px;margin-top:5px;height:18px}
.tb{width:7px;border-radius:2px 2px 0 0}

/* ─── ALLERGY ROW ─── */
.allergy-row{
  background:#fff8ed;border:1px solid #fde68a;border-radius:var(--r-sm);
  padding:8px 14px;display:flex;align-items:center;gap:8px;
  margin-bottom:12px;font-size:12.5px;color:#92400e;
}

/* ─── GRID ─── */
.grid2{display:grid;grid-template-columns:1fr 1fr;gap:12px;margin-bottom:12px}
.grid3{display:grid;grid-template-columns:1fr 1fr 1fr;gap:12px;margin-bottom:12px}

.card{background:var(--white);border-radius:var(--r);box-shadow:var(--shadow);overflow:hidden}
.card-hd{
  display:flex;align-items:center;justify-content:space-between;
  padding:12px 15px 10px;border-bottom:1px solid var(--gray-100);
}
.card-title{font-weight:700;font-size:13px;color:var(--navy);display:flex;align-items:center;gap:6px}
.card-menu{color:var(--gray-400);cursor:pointer;letter-spacing:2px}
.card-bd{padding:13px 15px}

/* ─── MED TABLE ─── */
.med-tbl{width:100%;border-collapse:collapse;font-size:12.5px}
.med-tbl th{
  text-align:left;padding:5px 7px;font-size:10.5px;
  text-transform:uppercase;letter-spacing:.6px;color:var(--gray-400);
  border-bottom:1px solid var(--gray-200);
}
.med-tbl td{padding:8px 7px;border-bottom:1px solid var(--gray-100);vertical-align:middle}
.med-tbl tr:last-child td{border-bottom:none}
.med-tbl tr.flagged{background:#fff9f9}
.mname{font-weight:600}
.mname.danger{color:var(--red)}
.mono{font-family:'JetBrains Mono',monospace;font-size:11.5px}
.dose-alert{color:var(--red);font-weight:600;display:flex;align-items:center;gap:3px}
.badge{padding:2px 7px;border-radius:20px;font-size:10px;font-weight:700;text-transform:uppercase}
.b-crit{background:#fee2e2;color:#b91c1c}
.b-major{background:#fef3c7;color:#d97706}
.chk{color:var(--green);font-size:15px}
.wrn{color:var(--red);font-size:13px}
.btn-add-med{
  width:100%;border:1.5px dashed var(--gray-200);background:none;
  color:var(--blue);font-size:12px;font-weight:600;padding:7px;
  border-radius:var(--r-sm);cursor:pointer;margin-top:10px;
  font-family:'Outfit',sans-serif;transition:background .2s;
}
.btn-add-med:hover{background:var(--blue-pale)}

/* ─── INTERACTION ─── */
.int-hd{background:var(--red);color:#fff;padding:11px 15px;display:flex;align-items:center;gap:7px;font-weight:700;font-size:13px}
.sev-tabs{display:flex;gap:6px;padding:10px 15px 0}
.sev-tab{padding:3px 10px;border-radius:20px;font-size:11px;font-weight:700;cursor:pointer;border:1.5px solid transparent}
.sev-tab.crit{background:#fee2e2;color:#b91c1c;border-color:#b91c1c}
.sev-tab.maj{background:#fef3c7;color:#d97706;border-color:#d97706}
.sev-tab.mod{background:#ecfdf5;color:#059669;border-color:#d1fae5}
.int-body{padding:12px 15px}
.int-pair{font-size:14px;font-weight:700;margin-bottom:3px}
.int-pair .plus{color:var(--gray-400);margin:0 4px}
.int-risk{font-size:12px;color:var(--gray-600);margin-bottom:9px}
.rec-box{background:var(--gray-50);border-left:3px solid var(--blue);padding:9px 11px;border-radius:0 var(--r-sm) var(--r-sm) 0;margin-bottom:11px}
.rec-lbl{font-size:10px;font-weight:700;text-transform:uppercase;letter-spacing:.5px;color:var(--blue);margin-bottom:3px}
.rec-txt{font-size:12px;color:var(--gray-700);line-height:1.5}
.int-actions{display:flex;gap:7px;flex-wrap:wrap}
.btn-blue{background:var(--blue);color:#fff;border:none;padding:7px 13px;border-radius:var(--r-sm);font-size:12px;font-weight:600;cursor:pointer;font-family:'Outfit',sans-serif;transition:background .2s}
.btn-blue:hover{background:var(--blue2)}
.btn-sec{background:var(--white);color:var(--gray-700);border:1.5px solid var(--gray-200);padding:7px 13px;border-radius:var(--r-sm);font-size:12px;font-weight:500;cursor:pointer;font-family:'Outfit',sans-serif;transition:background .2s}
.btn-sec:hover{background:var(--gray-100)}
.btn-ovr{background:#fff8ed;color:#d97706;border:1.5px solid #fcd34d;padding:7px 13px;border-radius:var(--r-sm);font-size:12px;font-weight:700;cursor:pointer;font-family:'Outfit',sans-serif;transition:background .2s}
.btn-ovr:hover{background:#fde68a}
.ovr-confirm{display:none;margin-top:10px;background:#fff8f0;border:1px solid #fcd34d;border-radius:var(--r-sm);padding:10px 12px;font-size:12px;color:#92400e}

/* ─── DOSING GUIDANCE (FIXED CHART) ─── */
.dosing-alert-box{background:var(--orange-lt);border:1px solid #fde68a;border-radius:var(--r-sm);padding:11px 13px;margin-bottom:12px}
.dosing-alert-title{font-weight:700;font-size:12.5px;color:var(--orange);margin-bottom:3px}
.dosing-alert-txt{font-size:12px;color:#92400e;line-height:1.5}

/* CLEAN CHART */
.egfr-section{margin-top:4px}
.egfr-chart-title{font-size:11px;font-weight:700;color:var(--gray-600);text-transform:uppercase;letter-spacing:.6px;margin-bottom:8px}
.egfr-chart-wrap{
  display:flex;align-items:flex-end;gap:0;
  height:80px;padding:0 4px;
  border-bottom:2px solid var(--gray-200);
  position:relative;
}
.egfr-col{
  flex:1;display:flex;flex-direction:column;align-items:center;
  justify-content:flex-end;padding:0 5px;
  gap:4px;
}
.egfr-bar-v{
  width:100%;max-width:32px;border-radius:4px 4px 0 0;
  transition:opacity .2s;cursor:pointer;
  position:relative;
}
.egfr-bar-v:hover{opacity:.8}
.egfr-val{font-size:10px;font-weight:700;color:var(--gray-800)}
.egfr-mo{font-size:10px;color:var(--gray-400);margin-top:5px}
.egfr-unit{font-size:10px;color:var(--gray-400);text-align:center;margin-top:4px}
.trend-arrow{font-size:11px;color:var(--red);font-weight:700;margin-left:4px}

.btn-review{
  width:100%;background:var(--blue);color:#fff;border:none;
  padding:8px;border-radius:var(--r-sm);font-size:12.5px;font-weight:600;
  cursor:pointer;margin-top:12px;font-family:'Outfit',sans-serif;transition:background .2s;
}
.btn-review:hover{background:var(--blue2)}

/* ─── COUNSELLING PANELS ─── */
.counsel-hd-drug{background:linear-gradient(135deg,#1e3a5f,#1a56db);color:#fff;padding:11px 15px;display:flex;align-items:center;justify-content:space-between}
.counsel-hd-cond{background:linear-gradient(135deg,#065f46,#059669);color:#fff;padding:11px 15px;display:flex;align-items:center;justify-content:space-between}
.counsel-title{font-weight:700;font-size:13px;display:flex;align-items:center;gap:6px}
.counsel-badge{background:rgba(255,255,255,.2);padding:2px 8px;border-radius:20px;font-size:10.5px;font-weight:700}

.counsel-point{
  display:flex;align-items:flex-start;gap:9px;
  padding:9px 10px;border-radius:var(--r-sm);
  border:1.5px solid var(--gray-100);margin-bottom:6px;
  background:#fff;transition:border-color .2s;
}
.counsel-point:hover{border-color:var(--gray-300)}
.counsel-point.approved{border-color:#a7f3d0;background:#f0fdf9}
.counsel-point.removed{border-color:#fecaca;background:#fff8f8;opacity:.6}
.cp-icon{font-size:16px;margin-top:1px;flex-shrink:0}
.cp-body{flex:1}
.cp-title{font-weight:600;font-size:12.5px;color:var(--gray-800);margin-bottom:2px}
.cp-text{font-size:12px;color:var(--gray-600);line-height:1.45}
.cp-actions{display:flex;gap:5px;margin-top:7px;flex-wrap:wrap}
.btn-approve{background:#ecfdf5;color:#059669;border:1.5px solid #6ee7b7;padding:3px 9px;border-radius:20px;font-size:11px;font-weight:700;cursor:pointer;font-family:'Outfit',sans-serif;transition:background .2s}
.btn-approve:hover{background:#d1fae5}
.btn-approve.active{background:#059669;color:#fff;border-color:#059669}
.btn-remove-cp{background:#fff0ef;color:#b91c1c;border:1.5px solid #fca5a5;padding:3px 9px;border-radius:20px;font-size:11px;font-weight:700;cursor:pointer;font-family:'Outfit',sans-serif;transition:background .2s}
.btn-remove-cp:hover{background:#fee2e2}
.btn-preview{background:var(--blue-pale);color:var(--blue);border:1.5px solid #93c5fd;padding:3px 9px;border-radius:20px;font-size:11px;font-weight:700;cursor:pointer;font-family:'Outfit',sans-serif;transition:background .2s}
.status-chip{padding:2px 8px;border-radius:20px;font-size:10px;font-weight:700;text-transform:uppercase}
.chip-approved{background:#d1fae5;color:#065f46}
.chip-pending{background:#fef3c7;color:#d97706}
.chip-removed{background:#fee2e2;color:#b91c1c}

.add-cp-row{display:flex;gap:6px;margin-top:8px}
.add-cp-input{
  flex:1;border:1.5px solid var(--gray-200);border-radius:var(--r-sm);
  padding:7px 10px;font-size:12px;font-family:'Outfit',sans-serif;
  outline:none;color:var(--gray-700);
}
.add-cp-input:focus{border-color:var(--blue)}
.btn-add-cp{background:var(--blue);color:#fff;border:none;padding:7px 12px;border-radius:var(--r-sm);font-size:12px;font-weight:600;cursor:pointer;font-family:'Outfit',sans-serif;white-space:nowrap}

.preview-modal{
  display:none;position:fixed;inset:0;background:rgba(10,22,40,.6);
  z-index:1000;align-items:center;justify-content:center;
}
.preview-modal.open{display:flex}
.preview-box{
  background:#fff;border-radius:14px;padding:28px 32px;max-width:520px;width:90%;
  box-shadow:0 20px 60px rgba(0,0,0,.3);position:relative;
}
.preview-box h3{font-size:16px;font-weight:700;color:var(--navy);margin-bottom:4px}
.preview-box p.subtitle{font-size:12px;color:var(--gray-400);margin-bottom:16px}
.preview-item{
  display:flex;align-items:flex-start;gap:8px;
  padding:8px 10px;background:var(--gray-50);border-radius:var(--r-sm);margin-bottom:6px;
}
.preview-item .pi-icon{font-size:14px;margin-top:1px}
.preview-item .pi-text{font-size:12.5px;color:var(--gray-700);line-height:1.4}
.preview-close{position:absolute;top:14px;right:16px;background:none;border:none;font-size:20px;cursor:pointer;color:var(--gray-400)}
.preview-footer{margin-top:16px;display:flex;justify-content:flex-end;gap:8px}
.btn-print-preview{background:var(--navy);color:#fff;border:none;padding:8px 18px;border-radius:var(--r-sm);font-size:12.5px;font-weight:600;cursor:pointer;font-family:'Outfit',sans-serif}

/* ─── AUDIT LOG ─── */
.audit-row{display:flex;align-items:center;gap:9px;padding:7px 0;border-bottom:1px solid var(--gray-100);font-size:12px}
.audit-row:last-child{border-bottom:none}
.a-dot{width:8px;height:8px;border-radius:50%;flex-shrink:0}
.a-dot.ovr{background:#d97706}
.a-dot.add{background:var(--blue)}
.a-dot.alert{background:var(--red)}
.a-txt{flex:1;color:var(--gray-700)}
.a-time{font-family:'JetBrains Mono',monospace;font-size:10.5px;color:var(--gray-400)}

/* ─── PRESCRIBER NOTES ─── */
.note-item{background:var(--gray-50);border-radius:var(--r-sm);padding:9px 11px;margin-bottom:6px}
.note-med{font-weight:700;color:var(--blue);font-size:11px;margin-bottom:2px}
.note-body{font-size:12.5px;color:var(--gray-700);line-height:1.45}
.note-date{font-size:11px;color:var(--gray-400);margin-top:4px;font-family:'JetBrains Mono',monospace}
textarea.note-inp{
  width:100%;border:1.5px solid var(--gray-200);border-radius:var(--r-sm);
  padding:8px 10px;font-size:12.5px;font-family:'Outfit',sans-serif;
  color:var(--gray-700);resize:none;outline:none;
}
textarea.note-inp:focus{border-color:var(--blue)}

/* ─── CHATBOT ─── */
.chat-fab-wrap{
  position:fixed;bottom:22px;right:22px;
  z-index:300;display:flex;flex-direction:column;align-items:center;gap:5px;
}
.chat-fab{
  width:64px;height:64px;border-radius:50%;
  background:linear-gradient(145deg,#0a1628 0%,#112240 45%,#1a4a8a 100%);
  box-shadow:0 4px 24px rgba(10,22,40,.55), 0 0 0 0 rgba(26,108,245,.5);
  display:flex;align-items:center;justify-content:center;
  cursor:pointer;border:2.5px solid rgba(91,163,255,.4);
  transition:transform .2s,box-shadow .2s;
  animation:fabPulse 2.8s ease-in-out infinite;
  position:relative;overflow:hidden;
}
.chat-fab::before{
  content:'';position:absolute;inset:0;border-radius:50%;
  background:conic-gradient(from 0deg, transparent 60%, rgba(91,163,255,.25) 80%, transparent 100%);
  animation:fabSpin 3s linear infinite;
}
@keyframes fabPulse{
  0%,100%{box-shadow:0 4px 24px rgba(10,22,40,.55),0 0 0 0 rgba(26,108,245,.45)}
  50%{box-shadow:0 6px 32px rgba(10,22,40,.65),0 0 0 8px rgba(26,108,245,.0)}
}
@keyframes fabSpin{from{transform:rotate(0deg)}to{transform:rotate(360deg)}}
.chat-fab:hover{transform:scale(1.1);box-shadow:0 8px 36px rgba(10,22,40,.7),0 0 0 4px rgba(91,163,255,.3)}
.chat-fab-label{
  font-family:'Outfit',sans-serif;font-size:9.5px;font-weight:700;
  color:#1a56db;letter-spacing:.6px;text-transform:uppercase;
  background:#fff;padding:2px 8px;border-radius:20px;
  box-shadow:0 2px 8px rgba(10,22,40,.15);
  white-space:nowrap;
}

.chat-panel{
  display:none;position:fixed;bottom:112px;right:22px;
  width:330px;height:440px;
  background:#fff;border-radius:16px;
  box-shadow:0 8px 40px rgba(10,22,40,.22);
  z-index:300;flex-direction:column;overflow:hidden;
  animation:slideUp .25s ease;
}
.chat-panel.open{display:flex}
@keyframes slideUp{from{opacity:0;transform:translateY(16px)}to{opacity:1;transform:translateY(0)}}
.chat-ph{
  background:linear-gradient(135deg,var(--navy),#1a3a6b);
  padding:12px 15px;display:flex;align-items:center;justify-content:space-between;
}
.chat-ph-left{display:flex;align-items:center;gap:9px}
.chat-ph-avatar{
  width:32px;height:32px;border-radius:50%;
  background:linear-gradient(135deg,#3d86ff,#60a5fa);
  display:flex;align-items:center;justify-content:center;font-size:16px;
}
.chat-ph-name{font-size:13px;font-weight:700;color:#fff}
.chat-ph-status{font-size:10.5px;color:#93c5fd}
.chat-close{background:none;border:none;color:#94a3b8;cursor:pointer;font-size:18px;line-height:1}
.chat-body{flex:1;overflow-y:auto;padding:12px;display:flex;flex-direction:column;gap:8px;background:#f7f9fc}
.msg{max-width:85%;padding:8px 11px;border-radius:10px;font-size:12.5px;line-height:1.5}
.msg.bot{background:#fff;color:var(--gray-800);align-self:flex-start;border:1px solid var(--gray-200);border-bottom-left-radius:3px}
.msg.user{background:var(--blue);color:#fff;align-self:flex-end;border-bottom-right-radius:3px}
.chat-suggestions{display:flex;flex-wrap:wrap;gap:5px;padding:0 12px 8px}
.chat-sug{
  background:var(--blue-pale);color:var(--blue);border:1px solid #bfdbfe;
  padding:4px 9px;border-radius:20px;font-size:11px;font-weight:600;cursor:pointer;
  transition:background .2s;font-family:'Outfit',sans-serif;
}
.chat-sug:hover{background:#dbeafe}
.chat-input-row{
  display:flex;align-items:center;gap:7px;
  padding:9px 12px;border-top:1px solid var(--gray-200);background:#fff;
}
.chat-input{
  flex:1;border:1.5px solid var(--gray-200);border-radius:20px;
  padding:6px 12px;font-size:12px;font-family:'Outfit',sans-serif;
  outline:none;color:var(--gray-700);
}
.chat-input:focus{border-color:var(--blue)}
.chat-send{
  background:var(--blue);color:#fff;border:none;
  width:32px;height:32px;border-radius:50%;cursor:pointer;
  display:flex;align-items:center;justify-content:center;flex-shrink:0;
  transition:background .2s;
}
.chat-send:hover{background:var(--blue2)}
.typing-indicator{display:flex;align-items:center;gap:3px;padding:8px 11px}
.typing-dot{width:7px;height:7px;background:var(--gray-400);border-radius:50%;animation:blink 1.2s infinite}
.typing-dot:nth-child(2){animation-delay:.2s}
.typing-dot:nth-child(3){animation-delay:.4s}
@keyframes blink{0%,80%,100%{opacity:.3}40%{opacity:1}}

/* ─── RESPONSIVE ─── */
@media(max-width:780px){
  .grid2,.grid3{grid-template-columns:1fr}
  .stat-row{grid-template-columns:1fr}
}
</style>
</head>
<body>

<!-- TOP NAV with enhanced SVG logo -->
<nav class="topnav">
  <a class="brand" href="#">
    <div class="brand-logo-wrap">
      <img src="data:image/png;base64,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" alt="VabGen Rx" class="brand-logo-img" />
      <div class="brand-logo-dot"></div>
    </div>
    <div class="brand-wrap">
      <div class="brand-text">
        <span class="vab">Vab</span><span class="gen">Gen</span><span class="rx"> Rx</span>
      </div>
      <div class="brand-tagline">Clinical Intelligence Platform</div>
    </div>
  </a>
  <div class="nav-right">
    <div class="nav-pill" style="flex-direction:column;align-items:flex-start;gap:1px;padding:4px 11px">
      <div style="display:flex;align-items:center;gap:6px">
        <svg width="14" height="14" fill="none" stroke="currentColor" stroke-width="1.8" viewBox="0 0 24 24"><path d="M20 21v-2a4 4 0 0 0-4-4H8a4 4 0 0 0-4 4v2"/><circle cx="12" cy="7" r="4"/></svg>
        <span style="font-size:13px;font-weight:600;color:#fff">Dr. Kang</span>
      </div>
      <span style="font-size:10px;color:#6b9fd4;font-weight:400;letter-spacing:.4px;padding-left:20px">Cardiology Consultant</span>
    </div>
    <div class="nav-pill">
      <svg width="14" height="14" fill="none" stroke="currentColor" stroke-width="1.8" viewBox="0 0 24 24"><path d="M18 8A6 6 0 0 0 6 8c0 7-3 9-3 9h18s-3-2-3-9"/><path d="M13.73 21a2 2 0 0 1-3.46 0"/></svg>
      Alerts <span class="notif-dot">2</span>
    </div>
    <div class="nav-pill">
      <svg width="14" height="14" fill="none" stroke="currentColor" stroke-width="1.8" viewBox="0 0 24 24"><path d="M9 21H5a2 2 0 0 1-2-2V5a2 2 0 0 1 2-2h4"/><polyline points="16 17 21 12 16 7"/><line x1="21" y1="12" x2="9" y2="12"/></svg>
      Logout
    </div>
  </div>
</nav>

<div class="main">

  <!-- PATIENT HEADER -->
  <div class="patient-header">
    <div class="pat-avatar">🧑</div>
    <div>
      <div class="pat-name">Mr. Jvue Raat</div>
      <div class="pat-meta">
        <span>Age: 68</span><span>ID: #1233456</span>
        <span class="cond-tag">Diabetes</span>
        <span class="cond-tag">Hypertension</span>
      </div>
    </div>
    <div class="allergy-strip" style="margin-left:auto">
      ⚠️ <strong>Allergies:</strong>&nbsp;Penicillin · Sulfonamides · Codeine
    </div>
  </div>

  <!-- RISK BANNER -->
  <div class="risk-banner">
    <div class="risk-l">
      <div class="risk-ring">!</div>
      <div>
        <div class="risk-label-sm">Composite Risk Score</div>
        <div class="risk-title">HIGH RISK — 2 Active Drug Alerts · Renal Impairment Detected</div>
      </div>
    </div>
    <button class="btn-wh">View Full Summary</button>
  </div>

  <!-- STAT CARDS -->
  <div class="stat-row">
    <div class="stat-card">
      <div class="stat-ico ico-blue">💊</div>
      <div>
        <div class="stat-num" style="color:var(--blue)">5</div>
        <div class="stat-lbl">Current Medications</div>
      </div>
    </div>
    <div class="stat-card">
      <div class="stat-ico ico-red">⚠️</div>
      <div>
        <div class="stat-num" style="color:var(--red)">2</div>
        <div class="stat-lbl">Interaction Alerts</div>
      </div>
    </div>
    <div class="stat-card">
      <div class="stat-ico ico-orange">🩺</div>
      <div>
        <div class="stat-num" style="color:var(--orange);font-size:20px">45 <span style="font-size:13px;font-weight:500">ml/min</span></div>
        <div class="stat-lbl">eGFR · Moderate Impairment</div>
        <div class="trend-bar-row">
          <div class="tb" style="height:14px;background:#4ade80"></div>
          <div class="tb" style="height:16px;background:#86efac"></div>
          <div class="tb" style="height:13px;background:#fbbf24"></div>
          <div class="tb" style="height:11px;background:#f97316"></div>
          <div class="tb" style="height:9px;background:#ef4444"></div>
          <span style="font-size:10px;color:var(--red);margin-left:5px">▼ trending</span>
        </div>
      </div>
    </div>
  </div>

  <!-- ROW 1: Meds + Interaction -->
  <div class="grid2">

    <!-- MEDICATION LIST -->
    <div class="card">
      <div class="card-hd">
        <div class="card-title">💊 Medication List</div>
        <div class="card-menu">•••</div>
      </div>
      <div style="padding:0 4px">
        <table class="med-tbl">
          <thead><tr><th>Medication</th><th>Dose</th><th>Severity</th><th>Status</th></tr></thead>
          <tbody>
            <tr><td><span class="mname">Metformin</span></td><td><span class="mono">1000 mg bid</span></td><td>—</td><td><span class="chk">✓</span></td></tr>
            <tr><td><span class="mname">Lisinopril</span></td><td><span class="mono">10 mg daily</span></td><td>—</td><td><span class="chk">✓</span></td></tr>
            <tr class="flagged"><td><span class="mname danger">Warfarin ⚠</span></td><td><span class="dose-alert">⚠ 10 mg daily</span></td><td><span class="badge b-crit">Critical</span></td><td><span class="wrn">?</span></td></tr>
            <tr class="flagged"><td><span class="mname danger">Bactrim</span></td><td><span class="mono">1 DS tab bid</span></td><td><span class="badge b-crit">Critical</span></td><td><span class="wrn">?</span></td></tr>
            <tr><td><span class="mname">Aspirin</span></td><td><span class="mono">81 mg daily</span></td><td><span class="badge b-major">Major</span></td><td><span class="chk">✓</span></td></tr>
          </tbody>
        </table>
      </div>
      <div style="padding:0 12px 12px">
        <button class="btn-add-med">+ Add Medication</button>
      </div>
    </div>

    <!-- INTERACTION WARNING -->
    <div class="card" style="overflow:hidden">
      <div class="int-hd">⚠️ Drug Interaction Warning</div>
      <div class="sev-tabs">
        <span class="sev-tab crit">Critical (1)</span>
        <span class="sev-tab maj">Major (1)</span>
        <span class="sev-tab mod">Moderate (0)</span>
      </div>
      <div class="int-body">
        <div class="int-pair">Warfarin <span class="plus">+</span> Bactrim</div>
        <div class="int-risk">Significantly increased bleeding risk — Bactrim inhibits Warfarin metabolism via CYP2C9</div>
        <div class="rec-box">
          <div class="rec-lbl">Recommendation</div>
          <div class="rec-txt">Consider alternative antibiotic: <strong>Azithromycin</strong> 500 mg × 1, then 250 mg daily × 4 days<br><em style="color:var(--red);font-size:11px">⚠ Note: Amoxicillin contraindicated — patient has Penicillin allergy</em></div>
        </div>
        <div class="int-actions">
          <button class="btn-blue">View Details</button>
          <button class="btn-ovr" onclick="showOvr()">Override ⚠</button>
        </div>
        <div class="ovr-confirm" id="ovr-box">
          ⚠️ <strong>Confirm Override?</strong> This will be logged with your credentials.<br>
          <div style="display:flex;gap:7px;margin-top:8px">
            <button class="btn-ovr" style="font-size:11px;padding:5px 10px" onclick="doOverride()">Yes, Override & Log</button>
            <button class="btn-sec" style="font-size:11px;padding:5px 10px" onclick="cancelOvr()">Cancel</button>
          </div>
        </div>
      </div>
    </div>
  </div>

  <!-- ROW 2: Dosing + Audit + Notes -->
  <div class="grid3">

    <!-- DOSING GUIDANCE — FIXED CHART -->
    <div class="card">
      <div class="card-hd">
        <div class="card-title">📐 Dosing Guidance</div>
        <div class="card-menu">•••</div>
      </div>
      <div class="card-bd">
        <div class="dosing-alert-box">
          <div class="dosing-alert-title">⚠ Renal Adjustment Required</div>
          <div class="dosing-alert-txt">Reduce Metformin dose — eGFR &lt; 45 ml/min. Hold if eGFR drops below 30.</div>
        </div>
        <div class="egfr-section">
          <div class="egfr-chart-title">eGFR Trend (ml/min) <span class="trend-arrow">▼ declining</span></div>
          <!-- Clean, non-overlapping bar chart -->
          <div class="egfr-chart-wrap">
            <div class="egfr-col">
              <div class="egfr-val">62</div>
              <div class="egfr-bar-v" style="height:62px;background:#4ade80"></div>
            </div>
            <div class="egfr-col">
              <div class="egfr-val">58</div>
              <div class="egfr-bar-v" style="height:56px;background:#86efac"></div>
            </div>
            <div class="egfr-col">
              <div class="egfr-val">53</div>
              <div class="egfr-bar-v" style="height:49px;background:#fbbf24"></div>
            </div>
            <div class="egfr-col">
              <div class="egfr-val">49</div>
              <div class="egfr-bar-v" style="height:43px;background:#f97316"></div>
            </div>
            <div class="egfr-col">
              <div class="egfr-val">45</div>
              <div class="egfr-bar-v" style="height:38px;background:#ef4444"></div>
            </div>
          </div>
          <!-- Month labels BELOW chart, not overlapping -->
          <div style="display:flex;padding:0 4px;margin-top:5px">
            <div style="flex:1;text-align:center"><span class="egfr-mo">Oct</span></div>
            <div style="flex:1;text-align:center"><span class="egfr-mo">Nov</span></div>
            <div style="flex:1;text-align:center"><span class="egfr-mo">Dec</span></div>
            <div style="flex:1;text-align:center"><span class="egfr-mo">Jan</span></div>
            <div style="flex:1;text-align:center"><span class="egfr-mo">Feb</span></div>
          </div>
          <div class="egfr-unit">ml / min</div>
        </div>
        <button class="btn-review">Review Dosing Plan</button>
      </div>
    </div>

    <!-- AUDIT LOG -->
    <div class="card">
      <div class="card-hd">
        <div class="card-title">📋 Override & Audit Log</div>
        <div class="card-menu">•••</div>
      </div>
      <div class="card-bd" id="audit-log">
        <div class="audit-row"><div class="a-dot alert"></div><div class="a-txt">Alert: Warfarin + Bactrim detected</div><div class="a-time">09:14 today</div></div>
        <div class="audit-row"><div class="a-dot add"></div><div class="a-txt">Bactrim DS added by Dr. Kang</div><div class="a-time">09:12 today</div></div>
        <div class="audit-row"><div class="a-dot ovr"></div><div class="a-txt">Warfarin dose reviewed — no change</div><div class="a-time">Jan 28</div></div>
        <div class="audit-row"><div class="a-dot add"></div><div class="a-txt">Aspirin 81 mg added — CV prophylaxis</div><div class="a-time">Jan 15</div></div>
        <div class="audit-row"><div class="a-dot add"></div><div class="a-txt">Metformin titrated to 1000 mg bid</div><div class="a-time">Jan 10</div></div>
      </div>
    </div>

    <!-- PRESCRIBER NOTES -->
    <div class="card">
      <div class="card-hd">
        <div class="card-title">📝 Prescriber Notes</div>
        <div class="card-menu">•••</div>
      </div>
      <div class="card-bd">
        <div class="note-item">
          <div class="note-med">Warfarin</div>
          <div class="note-body">INR target 2.0–3.0. Last INR 2.4 on Jan 20 — within range. Monitor closely with new antibiotic.</div>
          <div class="note-date">Jan 20 · Dr. Kang</div>
        </div>
        <div class="note-item">
          <div class="note-med">Bactrim DS</div>
          <div class="note-body">Started for UTI — 7-day course. Childhood sulfonamide allergy reassessed as mild, tolerable with monitoring.</div>
          <div class="note-date">Today · Dr. Kang</div>
        </div>
        <textarea class="note-inp" rows="2" placeholder="Add a clinical note..."></textarea>
        <button class="btn-blue" style="margin-top:7px;font-size:12px;padding:6px 12px">Save Note</button>
      </div>
    </div>
  </div>

  <!-- ROW 3: DRUG COUNSELLING + CONDITION COUNSELLING -->
  <div class="grid2">

    <!-- DRUG COUNSELLING -->
    <div class="card">
      <div class="counsel-hd-drug">
        <div class="counsel-title">💊 Drug Counselling <span class="counsel-badge" id="drug-count">4 points</span></div>
        <button class="btn-wh" style="font-size:11px;padding:4px 10px" onclick="openPreview('drug')">👁 Preview for Patient</button>
      </div>
      <div class="card-bd">
        <div id="drug-points">

          <div class="counsel-point approved" data-id="d1">
            <div class="cp-icon">🩸</div>
            <div class="cp-body">
              <div class="cp-title">Bleeding Risk — Warfarin</div>
              <div class="cp-text">Watch for unusual bruising, blood in urine/stool, prolonged bleeding from cuts. Seek emergency help immediately.</div>
              <div class="cp-actions">
                <span class="status-chip chip-approved">✓ Approved</span>
                <button class="btn-remove-cp" onclick="removePoint('d1','drug')">Remove</button>
                <button class="btn-preview" onclick="openPreview('drug')">Preview</button>
              </div>
            </div>
          </div>

          <div class="counsel-point approved" data-id="d2">
            <div class="cp-icon">🥗</div>
            <div class="cp-body">
              <div class="cp-title">Diet — Vitamin K Interaction</div>
              <div class="cp-text">Avoid major changes to Vitamin K intake (leafy greens). Consistency in diet helps maintain stable INR levels.</div>
              <div class="cp-actions">
                <span class="status-chip chip-approved">✓ Approved</span>
                <button class="btn-remove-cp" onclick="removePoint('d2','drug')">Remove</button>
                <button class="btn-preview" onclick="openPreview('drug')">Preview</button>
              </div>
            </div>
          </div>

          <div class="counsel-point" data-id="d3">
            <div class="cp-icon">⏰</div>
            <div class="cp-body">
              <div class="cp-title">Medication Timing</div>
              <div class="cp-text">Take Warfarin at the same time each day. Do not double dose if missed. Do not stop without consulting your doctor.</div>
              <div class="cp-actions">
                <span class="status-chip chip-pending" id="status-d3">Pending</span>
                <button class="btn-approve" id="approve-d3" onclick="approvePoint('d3')">✓ Approve</button>
                <button class="btn-remove-cp" onclick="removePoint('d3','drug')">Remove</button>
                <button class="btn-preview" onclick="openPreview('drug')">Preview</button>
              </div>
            </div>
          </div>

          <div class="counsel-point" data-id="d4">
            <div class="cp-icon">🧪</div>
            <div class="cp-body">
              <div class="cp-title">INR Monitoring</div>
              <div class="cp-text">Schedule INR check within 3–5 days of starting or stopping any antibiotic. Report any bleeding symptoms immediately.</div>
              <div class="cp-actions">
                <span class="status-chip chip-pending" id="status-d4">Pending</span>
                <button class="btn-approve" id="approve-d4" onclick="approvePoint('d4')">✓ Approve</button>
                <button class="btn-remove-cp" onclick="removePoint('d4','drug')">Remove</button>
                <button class="btn-preview" onclick="openPreview('drug')">Preview</button>
              </div>
            </div>
          </div>

        </div>
        <div class="add-cp-row">
          <input class="add-cp-input" id="drug-new-input" placeholder="Add new drug counselling point...">
          <button class="btn-add-cp" onclick="addPoint('drug')">+ Add</button>
        </div>
      </div>
    </div>

    <!-- CONDITION COUNSELLING -->
    <div class="card">
      <div class="counsel-hd-cond">
        <div class="counsel-title">🏥 Condition Counselling <span class="counsel-badge" id="cond-count">4 points</span></div>
        <button class="btn-wh" style="font-size:11px;padding:4px 10px" onclick="openPreview('cond')">👁 Preview for Patient</button>
      </div>
      <div class="card-bd">
        <div id="cond-points">

          <div class="counsel-point approved" data-id="c1">
            <div class="cp-icon">🩺</div>
            <div class="cp-body">
              <div class="cp-title">Diabetes — Blood Sugar Monitoring</div>
              <div class="cp-text">Check fasting blood glucose daily. Target: 80–130 mg/dL before meals. Report readings above 250 mg/dL to your doctor.</div>
              <div class="cp-actions">
                <span class="status-chip chip-approved">✓ Approved</span>
                <button class="btn-remove-cp" onclick="removePoint('c1','cond')">Remove</button>
                <button class="btn-preview" onclick="openPreview('cond')">Preview</button>
              </div>
            </div>
          </div>

          <div class="counsel-point approved" data-id="c2">
            <div class="cp-icon">💓</div>
            <div class="cp-body">
              <div class="cp-title">Hypertension — BP Management</div>
              <div class="cp-text">Monitor blood pressure at home twice daily. Target: below 130/80 mmHg. Reduce sodium intake and avoid smoking.</div>
              <div class="cp-actions">
                <span class="status-chip chip-approved">✓ Approved</span>
                <button class="btn-remove-cp" onclick="removePoint('c2','cond')">Remove</button>
                <button class="btn-preview" onclick="openPreview('cond')">Preview</button>
              </div>
            </div>
          </div>

          <div class="counsel-point" data-id="c3">
            <div class="cp-icon">🏃</div>
            <div class="cp-body">
              <div class="cp-title">Lifestyle — Exercise & Diet</div>
              <div class="cp-text">Aim for 30 minutes of moderate activity 5 days/week. Follow a low-glycaemic, low-sodium diet. Avoid alcohol excess.</div>
              <div class="cp-actions">
                <span class="status-chip chip-pending" id="status-c3">Pending</span>
                <button class="btn-approve" id="approve-c3" onclick="approvePoint('c3')">✓ Approve</button>
                <button class="btn-remove-cp" onclick="removePoint('c3','cond')">Remove</button>
                <button class="btn-preview" onclick="openPreview('cond')">Preview</button>
              </div>
            </div>
          </div>

          <div class="counsel-point" data-id="c4">
            <div class="cp-icon">🔁</div>
            <div class="cp-body">
              <div class="cp-title">Renal Health — Follow-up</div>
              <div class="cp-text">Kidney function is declining (eGFR trend). Stay well hydrated. Avoid NSAIDs. Schedule nephrology follow-up within 4 weeks.</div>
              <div class="cp-actions">
                <span class="status-chip chip-pending" id="status-c4">Pending</span>
                <button class="btn-approve" id="approve-c4" onclick="approvePoint('c4')">✓ Approve</button>
                <button class="btn-remove-cp" onclick="removePoint('c4','cond')">Remove</button>
                <button class="btn-preview" onclick="openPreview('cond')">Preview</button>
              </div>
            </div>
          </div>

        </div>
        <div class="add-cp-row">
          <input class="add-cp-input" id="cond-new-input" placeholder="Add new condition counselling point...">
          <button class="btn-add-cp" onclick="addPoint('cond')">+ Add</button>
        </div>
      </div>
    </div>
  </div>

</div><!-- /main -->

<!-- ─── PREVIEW MODAL ─── -->
<div class="preview-modal" id="preview-modal">
  <div class="preview-box">
    <button class="preview-close" onclick="closePreview()">✕</button>
    <h3 id="preview-title">Patient Counselling Preview</h3>
    <p class="subtitle" id="preview-subtitle">Approved points that will be printed for the patient</p>
    <div id="preview-items"></div>
    <div class="preview-footer">
      <button class="btn-sec" onclick="closePreview()">Close</button>
      <button class="btn-print-preview" onclick="window.print()">🖨 Print for Patient</button>
    </div>
  </div>
</div>

<!-- ─── CHATBOT FAB ─── -->
<div class="chat-fab-wrap">
  <button class="chat-fab" onclick="toggleChat()" title="Vabgen Rx AI Assistant">
    <svg width="44" height="44" viewBox="0 0 44 44" fill="none">
      <!-- LEFT: AI Robot head -->
      <!-- robot skull -->
      <rect x="3" y="10" width="15" height="14" rx="3.5" fill="none" stroke="#5ba3ff" stroke-width="1.4"/>
      <!-- robot antenna -->
      <line x1="10.5" y1="10" x2="10.5" y2="7" stroke="#5ba3ff" stroke-width="1.3"/>
      <circle cx="10.5" cy="6" r="1.4" fill="#60a5fa"/>
      <!-- robot eye — gear shape suggestion -->
      <circle cx="8" cy="17" r="2" fill="none" stroke="#93c5fd" stroke-width="1.2"/>
      <circle cx="8" cy="17" r=".8" fill="#60a5fa"/>
      <circle cx="13" cy="17" r="2" fill="none" stroke="#93c5fd" stroke-width="1.2"/>
      <circle cx="13" cy="17" r=".8" fill="#60a5fa"/>
      <!-- robot mouth circuit line -->
      <path d="M7 21.5h7" stroke="#5ba3ff" stroke-width="1.1" stroke-linecap="round"/>
      <circle cx="7" cy="21.5" r=".9" fill="#60a5fa"/>
      <circle cx="14" cy="21.5" r=".9" fill="#60a5fa"/>
      <!-- robot body hint -->
      <rect x="5" y="24" width="11" height="5" rx="2" fill="none" stroke="#3d86ff" stroke-width="1.2"/>
      <line x1="10.5" y1="24" x2="10.5" y2="29" stroke="#3d86ff" stroke-width="1"/>

      <!-- CENTER: Light-bulb idea spark -->
      <path d="M22 13 L22 9" stroke="#fbbf24" stroke-width="1.5" stroke-linecap="round"/>
      <circle cx="22" cy="17.5" r="3.5" fill="none" stroke="#fbbf24" stroke-width="1.4"/>
      <path d="M20.5 21h3" stroke="#fbbf24" stroke-width="1.3" stroke-linecap="round"/>
      <path d="M21 22.5h2" stroke="#fbbf24" stroke-width="1.1" stroke-linecap="round"/>
      <!-- spark rays -->
      <line x1="16.5" y1="13.5" x2="15.2" y2="12.2" stroke="#fde68a" stroke-width="1.1" stroke-linecap="round"/>
      <line x1="27.5" y1="13.5" x2="28.8" y2="12.2" stroke="#fde68a" stroke-width="1.1" stroke-linecap="round"/>
      <line x1="15.5" y1="17.5" x2="13.8" y2="17.5" stroke="#fde68a" stroke-width="1.1" stroke-linecap="round"/>
      <line x1="28.5" y1="17.5" x2="30.2" y2="17.5" stroke="#fde68a" stroke-width="1.1" stroke-linecap="round"/>

      <!-- RIGHT: Doctor head -->
      <!-- head -->
      <circle cx="33.5" cy="14" r="5.5" fill="none" stroke="#a7f3d0" stroke-width="1.4"/>
      <!-- hair suggestion -->
      <path d="M28.5 13c0-3 2.2-5.5 5-5.5s5 2.5 5 5.5" stroke="#6ee7b7" stroke-width="1.3" fill="none"/>
      <!-- eyes -->
      <circle cx="31.5" cy="14" r=".9" fill="#a7f3d0"/>
      <circle cx="35.5" cy="14" r=".9" fill="#a7f3d0"/>
      <!-- mouth smile -->
      <path d="M31 17c.7 1 3.2 1 4 0" stroke="#a7f3d0" stroke-width="1.1" fill="none" stroke-linecap="round"/>
      <!-- doctor coat collar -->
      <path d="M28 19.5 C28 24 29 26 33.5 27 C38 26 39 24 39 19.5" fill="none" stroke="#d1fae5" stroke-width="1.3"/>
      <!-- stethoscope hint -->
      <path d="M31 22 Q30 25 32 26 Q34 27 34 25 Q34 23 33 22" fill="none" stroke="#6ee7b7" stroke-width="1.1" stroke-linecap="round"/>
      <circle cx="32" cy="26.5" r="1" fill="#6ee7b7"/>
    </svg>
  </button>
  <div class="chat-fab-label">AI Consult</div>
</div>

<!-- ─── CHAT PANEL ─── -->
<div class="chat-panel" id="chat-panel">
  <div class="chat-ph">
    <div class="chat-ph-left">
      <div class="chat-ph-avatar">
        <svg width="20" height="20" viewBox="0 0 44 44" fill="none">
          <rect x="3" y="10" width="15" height="14" rx="3.5" fill="none" stroke="#93c5fd" stroke-width="1.6"/>
          <line x1="10.5" y1="10" x2="10.5" y2="7" stroke="#93c5fd" stroke-width="1.4"/>
          <circle cx="10.5" cy="6" r="1.5" fill="#60a5fa"/>
          <circle cx="8" cy="17" r="1.8" fill="none" stroke="#bfdbfe" stroke-width="1.2"/><circle cx="8" cy="17" r=".7" fill="#93c5fd"/>
          <circle cx="13" cy="17" r="1.8" fill="none" stroke="#bfdbfe" stroke-width="1.2"/><circle cx="13" cy="17" r=".7" fill="#93c5fd"/>
          <path d="M22 13L22 9" stroke="#fbbf24" stroke-width="1.5" stroke-linecap="round"/>
          <circle cx="22" cy="17" r="3.2" fill="none" stroke="#fbbf24" stroke-width="1.4"/>
          <circle cx="33.5" cy="14" r="5.5" fill="none" stroke="#6ee7b7" stroke-width="1.4"/>
          <circle cx="31.5" cy="14" r=".9" fill="#a7f3d0"/><circle cx="35.5" cy="14" r=".9" fill="#a7f3d0"/>
          <path d="M31 17c.7 1 3.2 1 4 0" stroke="#a7f3d0" stroke-width="1.1" fill="none" stroke-linecap="round"/>
        </svg>
      </div>
      <div>
        <div class="chat-ph-name">Vabgen Rx Assistant</div>
        <div class="chat-ph-status">● Online — Clinical AI</div>
      </div>
    </div>
    <button class="chat-close" onclick="toggleChat()">✕</button>
  </div>
  <div class="chat-body" id="chat-body">
    <div class="msg bot">👋 Hello Dr. Kang! I'm your Vabgen Rx clinical assistant. I can help with drug interactions, dosing guidance, or patient counselling for Mr. Jvue Raat.</div>
  </div>
  <div class="chat-suggestions" id="chat-sugs">
    <button class="chat-sug" onclick="askBot('Why is Warfarin + Bactrim dangerous?')">Warfarin + Bactrim risk?</button>
    <button class="chat-sug" onclick="askBot('Suggest alternatives to Bactrim for this patient')">Suggest alternatives</button>
    <button class="chat-sug" onclick="askBot('What is the Metformin dose adjustment for eGFR 45?')">Metformin dose adjust?</button>
    <button class="chat-sug" onclick="askBot('Summarise key counselling points for Mr. Jvue Raat')">Counselling summary</button>
  </div>
  <div class="chat-input-row">
    <input class="chat-input" id="chat-input" placeholder="Ask a clinical question..." onkeydown="if(event.key==='Enter')sendChat()">
    <button class="chat-send" onclick="sendChat()">
      <svg width="14" height="14" fill="none" stroke="#fff" stroke-width="2" viewBox="0 0 24 24"><line x1="22" y1="2" x2="11" y2="13"/><polygon points="22 2 15 22 11 13 2 9 22 2"/></svg>
    </button>
  </div>
</div>

<script>
// ── OVERRIDE ──
function showOvr(){document.getElementById('ovr-box').style.display='block'}
function cancelOvr(){document.getElementById('ovr-box').style.display='none'}
function doOverride(){
  document.getElementById('ovr-box').style.display='none';
  const log=document.getElementById('audit-log');
  const row=document.createElement('div');row.className='audit-row';
  const t=new Date();
  row.innerHTML=`<div class="a-dot ovr"></div><div class="a-txt"><strong>Override applied</strong> — Warfarin + Bactrim by Dr. Kang</div><div class="a-time">${t.getHours()}:${String(t.getMinutes()).padStart(2,'0')} today</div>`;
  log.prepend(row);
  row.style.background='#fff8f0';
  setTimeout(()=>row.style.background='',2500);
}

// ── APPROVE POINT ──
function approvePoint(id){
  const el=document.querySelector('[data-id="'+id+'"]');
  if(!el)return;
  el.classList.add('approved');
  const chip=document.getElementById('status-'+id);
  const btn=document.getElementById('approve-'+id);
  if(chip){chip.className='status-chip chip-approved';chip.textContent='✓ Approved'}
  if(btn)btn.remove();
}

// ── REMOVE POINT ──
function removePoint(id,type){
  const el=document.querySelector('[data-id="'+id+'"]');
  if(!el)return;
  el.style.transition='opacity .3s, max-height .3s';
  el.style.opacity='0';
  el.style.maxHeight='0';
  el.style.overflow='hidden';
  el.style.marginBottom='0';
  setTimeout(()=>{el.remove();updateCount(type)},350);
  updateCount(type);
}
function updateCount(type){
  const container=document.getElementById(type+'-points');
  const count=container?container.querySelectorAll('.counsel-point').length:0;
  const badge=document.getElementById(type+'-count');
  if(badge)badge.textContent=count+' points';
}

// ── ADD POINT ──
function addPoint(type){
  const inp=document.getElementById(type+'-new-input');
  const txt=inp.value.trim();
  if(!txt)return;
  const container=document.getElementById(type+'-points');
  const id=type+'_'+Date.now();
  const icons=['💡','📌','🔔','📋','ℹ️','🗒️'];
  const icon=icons[Math.floor(Math.random()*icons.length)];
  const div=document.createElement('div');
  div.className='counsel-point';div.dataset.id=id;
  div.innerHTML=`
    <div class="cp-icon">${icon}</div>
    <div class="cp-body">
      <div class="cp-title">Custom Point</div>
      <div class="cp-text">${txt}</div>
      <div class="cp-actions">
        <span class="status-chip chip-pending" id="status-${id}">Pending</span>
        <button class="btn-approve" id="approve-${id}" onclick="approvePoint('${id}')">✓ Approve</button>
        <button class="btn-remove-cp" onclick="removePoint('${id}','${type}')">Remove</button>
        <button class="btn-preview" onclick="openPreview('${type}')">Preview</button>
      </div>
    </div>`;
  container.appendChild(div);
  inp.value='';
  updateCount(type);
}

// ── PREVIEW MODAL ──
function openPreview(type){
  const modal=document.getElementById('preview-modal');
  const items=document.getElementById('preview-items');
  const title=document.getElementById('preview-title');
  const subtitle=document.getElementById('preview-subtitle');
  const container=document.getElementById(type+'-points');
  const approved=container.querySelectorAll('.counsel-point.approved');
  title.textContent=type==='drug'?'Drug Counselling — Patient Preview':'Condition Counselling — Patient Preview';
  subtitle.textContent=`${approved.length} approved point(s) ready to print for Mr. Jvue Raat`;
  items.innerHTML='';
  approved.forEach(p=>{
    const t=p.querySelector('.cp-title')?.textContent||'';
    const b=p.querySelector('.cp-text')?.textContent||'';
    const ic=p.querySelector('.cp-icon')?.textContent||'•';
    const d=document.createElement('div');d.className='preview-item';
    d.innerHTML=`<div class="pi-icon">${ic}</div><div class="pi-text"><strong>${t}:</strong> ${b}</div>`;
    items.appendChild(d);
  });
  if(!approved.length){items.innerHTML='<div style="color:var(--gray-400);font-size:12.5px;text-align:center;padding:20px 0">No approved points yet. Approve points to include them in the patient handout.</div>'}
  modal.classList.add('open');
}
function closePreview(){document.getElementById('preview-modal').classList.remove('open')}

// ── CHATBOT ──
let chatOpen=false;
function toggleChat(){
  chatOpen=!chatOpen;
  const p=document.getElementById('chat-panel');
  if(chatOpen)p.classList.add('open');else p.classList.remove('open');
}
function askBot(q){
  document.getElementById('chat-sugs').style.display='none';
  addUserMsg(q);
  showTyping();
  const responses={
    'Why is Warfarin + Bactrim dangerous?':'Bactrim (trimethoprim-sulfamethoxazole) inhibits the CYP2C9 enzyme responsible for Warfarin metabolism, leading to significantly elevated Warfarin plasma levels. This dramatically increases the risk of serious bleeding events including intracranial hemorrhage. Immediate dose review and close INR monitoring are essential.',
    'Suggest alternatives to Bactrim for this patient':'Given the Warfarin interaction and documented Penicillin allergy, safer alternatives include:\n• **Azithromycin** 500mg day 1, then 250mg × 4 days\n• **Nitrofurantoin** (if UTI is lower tract, confirm eGFR adequate)\nAvoid Ciprofloxacin (also interacts with Warfarin via CYP1A2).',
    'What is the Metformin dose adjustment for eGFR 45?':'For eGFR 45 ml/min (G3a CKD):\n• Metformin is still permissible but with caution\n• Reduce dose to 500–850 mg bid (not 1000 mg bid)\n• Review every 3–6 months\n• Hold if eGFR drops below 30 ml/min or during acute illness/contrast procedures.',
    'Summarise key counselling points for Mr. Jvue Raat':'Key counselling for Mr. Jvue Raat:\n🩸 Bleeding risk — monitor for bruising, blood in urine/stool\n🥗 Avoid sudden Vit K dietary changes (Warfarin interaction)\n🧪 INR check needed within 3–5 days of antibiotic change\n💊 Blood glucose target: 80–130 mg/dL fasting\n💓 BP target: <130/80 mmHg\n🔁 Nephrology follow-up in 4 weeks (declining eGFR)'
  };
  const reply=responses[q]||'I\'m analysing your query against the patient profile. For complex clinical decisions, please consult the latest clinical guidelines or your pharmacist.';
  setTimeout(()=>{removeTyping();addBotMsg(reply)},1400);
}
function sendChat(){
  const inp=document.getElementById('chat-input');
  const q=inp.value.trim();
  if(!q)return;
  inp.value='';
  document.getElementById('chat-sugs').style.display='none';
  addUserMsg(q);
  showTyping();
  setTimeout(()=>{
    removeTyping();
    addBotMsg('Based on John Doe\'s profile (Warfarin, renal impairment, known allergies), I recommend reviewing this with your clinical guidelines. For specific drug-drug interactions, the interaction panel above provides real-time severity data.');
  },1600);
}
function addUserMsg(txt){
  const b=document.getElementById('chat-body');
  const m=document.createElement('div');m.className='msg user';m.textContent=txt;
  b.appendChild(m);b.scrollTop=b.scrollHeight;
}
function addBotMsg(txt){
  const b=document.getElementById('chat-body');
  const m=document.createElement('div');m.className='msg bot';
  m.innerHTML=txt.replace(/\n/g,'<br>').replace(/\*\*(.*?)\*\*/g,'<strong>$1</strong>');
  b.appendChild(m);b.scrollTop=b.scrollHeight;
}
let typingEl=null;
function showTyping(){
  const b=document.getElementById('chat-body');
  typingEl=document.createElement('div');typingEl.className='msg bot';
  typingEl.innerHTML='<div class="typing-indicator"><div class="typing-dot"></div><div class="typing-dot"></div><div class="typing-dot"></div></div>';
  b.appendChild(typingEl);b.scrollTop=b.scrollHeight;
}
function removeTyping(){if(typingEl){typingEl.remove();typingEl=null}}
</script>

</body>
</html>
